129 related articles for article (PubMed ID: 8869907)
1. Modulation of experimental systemic lupus erythematosus with linomide.
Zandman-Goddard G; George J; Levy Y; Blank M; Slavin S; Shoenfeld Y
Lupus; 1996 Aug; 5(4):328-33. PubMed ID: 8869907
[TBL] [Abstract][Full Text] [Related]
2. Superantigens and experimental SLE induced by idiotypic dysregulation.
Baharav E; Gur H; Fishman P; Ziporen L; Blank M; Aelion J; Kotb M; Shoenfeld Y
Clin Exp Rheumatol; 1996; 14(4):359-66. PubMed ID: 8871833
[TBL] [Abstract][Full Text] [Related]
3. The effects of early and late administration of M-20 derived interleukin-1 inhibitor on experimental systemic lupus erythematosus.
Zandman-Goddard G; George J; Bland M; Levy Y; Yanai P; Halperin T; Shoenfeld Y; Barak V
Immunol Lett; 1996 Nov; 53(2-3):77-82. PubMed ID: 9024982
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide.
Karussis DM; Lehmann D; Slavin S; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Ben-Nun A; Kalland T; Abramsky O
Ann Neurol; 1993 Nov; 34(5):654-60. PubMed ID: 8239559
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin.
Krause I; Blank M; Kopolovic J; Afek A; Goldberg I; Tomer Y; Shoenfeld Y
J Rheumatol; 1995 Jun; 22(6):1068-74. PubMed ID: 7545755
[TBL] [Abstract][Full Text] [Related]
6. Systemic lupus erythematosus-related autoantibody production in mice is determined by bone marrow-derived cells.
Levite M; Zinger H; Mozes E; Reisner Y
Bone Marrow Transplant; 1993 Sep; 12(3):179-83. PubMed ID: 8241973
[TBL] [Abstract][Full Text] [Related]
7. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
[TBL] [Abstract][Full Text] [Related]
8. Induction of experimental systemic lupus erythematosus in mice by immunization with a monoclonal anti-La autoantibody.
Fricke H; Offen D; Mendlovic S; Shoenfeld Y; Bakimer R; Sperling J; Mozes E
Int Immunol; 1990; 2(3):225-30. PubMed ID: 2088487
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of diabetes in NOD mice by idiotypic induction of SLE.
Krause I; Tomer Y; Elias D; Blank M; Gilburd B; Cohen IR; Shoenfeld Y
J Autoimmun; 1999 Aug; 13(1):49-55. PubMed ID: 10441167
[TBL] [Abstract][Full Text] [Related]
10. Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype.
Mendlovic S; Brocke S; Shoenfeld Y; Ben-Bassat M; Meshorer A; Bakimer R; Mozes E
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2260-4. PubMed ID: 3258423
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).
Karussis DM; Lehmann D; Slavin S; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Kalland T; Abramsky O
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6400-4. PubMed ID: 8341645
[TBL] [Abstract][Full Text] [Related]
12. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
[TBL] [Abstract][Full Text] [Related]
13. Neonatal lupus erythematosus in offspring of mothers with experimental systemic lupus erythematosus.
Kalush F; Rimon E; Mozes E
Am J Reprod Immunol; 1992; 28(3-4):264-8. PubMed ID: 1285898
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
[TBL] [Abstract][Full Text] [Related]
15. Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype.
Tincani A; Balestrieri G; Allegri F; Cattaneo R; Fornasieri A; Li M; Sinico A; D'Amico G
Clin Exp Rheumatol; 1993; 11(2):129-34. PubMed ID: 7685255
[TBL] [Abstract][Full Text] [Related]
16. Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype.
Blank M; Krause I; Ben-Bassat M; Shoenfeld Y
J Autoimmun; 1992 Aug; 5(4):495-509. PubMed ID: 1418290
[TBL] [Abstract][Full Text] [Related]
17. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.
Wen ZK; Xu W; Xu L; Cao QH; Wang Y; Chu YW; Xiong SD
Rheumatology (Oxford); 2007 Dec; 46(12):1796-803. PubMed ID: 18032537
[TBL] [Abstract][Full Text] [Related]
18. The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations.
Dayan M; Zinger H; Kalush F; Mor G; Amir-Zaltzman Y; Kohen F; Sthoeger Z; Mozes E
Immunology; 1997 Jan; 90(1):101-8. PubMed ID: 9038719
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation of murine experimental SLE-like disease by interferon-gamma.
Amital H; Levi Y; Blank M; Barak V; Langevitz P; Afek A; Nicoletti F; Kopolovic J; Gilburd B; Meroni PL; Shoenfeld Y
Lupus; 1998; 7(7):445-54. PubMed ID: 9796846
[TBL] [Abstract][Full Text] [Related]
20. Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells.
Blank M; Krause I; Buskila D; Teitelbaum D; Kopolovic J; Afek A; Goldberg I; Shoenfeld Y
Cell Immunol; 1995 Apr; 162(1):114-22. PubMed ID: 7704899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
